Welcome to the 8th Oncolytic Virotherapy Summit: Engineering Oncolytic Viruses Towards Revolutionary Anti-Cancer Immunotherapies, happening from December 12 to December 14, 2023. Recent years witnessed rapid strides in oncolytic virotherapies, recognized for their potential in revolutionizing cancer immunotherapy. The past 3 months marked the entry of 20 new drugs into pre-clinical and clinical phases, along with FDA Fast Track Designation for Candel Therapeutics OV candidate. Join 100+ trailblazers in sessions covering Early Discovery, Translation, Clinical Development, CMC, and Regulations, addressing critical industry bottlenecks and manufacturing challenges for successful oncolytic virus production and stability. Gain insights from VYRIAD and Circio Bio on raw materials, supply chain management, and viral vector stability.
[Read on oncolytic-virotherapy](https://oncolytic-virotherapy-summit.com/)
The 6th RNA Targeted Drug Discovery & Development Summit brings together 200+ experts in RNA targeting from Large Pharma, Biotech, and Academia. With AI advancements and strategic collaborations, the event covers end-to-end RNA drug development: from target validation to lead optimization. New for 2023, an extra content stream focuses on preclinical and translation. Expert speakers from Novartis, Atomic AI, ReviR Therapeutics, Pfizer, and xFOREST Therapeutics will share insights. Access a full day on RNA target identification and validation, addressing challenges like RNA structure and binding regions. Join the summit to drive safe and effective RNA-based drugs into the clinic.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our